Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vaccine

Showing results (81-90 of 29,276) with videos related to

Pageof 2,928
Sort By:
Vaccine|June 8, 2001
Protective immunity against influenza A virus induced by immunization with DNA plasmid containing influenza M geneK Okuda, A Ihata, S Watabe, et al.
Vaccine|June 8, 2001
Plasmid DNA-recombinant Opc protein complexes for nasal DNA immunizationA Musacchio, D Quintana, A M Herrera, et al.
Vaccine|June 8, 2001
Antibody, cytokine and cytotoxic T lymphocyte responses in chimpanzees immunized with human papillomavirus virus-like particlesT J Palker, J M Monteiro, M M Martin, et al.
Vaccine|June 8, 2001
Vaxfectin enhances antigen specific antibody titers and maintains Th1 type immune responses to plasmid DNA immunizationL Reyes, J Hartikka, V Bozoukova, et al.
Vaccine|June 8, 2001
Intranasal immunogenicity of a Delta cya Delta crp-pabA mutant of Salmonella enterica serotype Typhimurium for the horseA S Sheoran, J F Timoney, S A Tinge, et al.
Vaccine|January 23, 2002
Mutant Escherichia coli heat-labile enterotoxin [LT(R192G)] enhances protective humoral and cellular immune responses to orally administered inactivated influenza vaccineXiuhua Lu, J D Clements, Jacqueline M Katz
Vaccine|January 23, 2002
Evaluation of a single dose of half strength inactivated influenza vaccine in healthy adultsJohn Treanor, Wendy Keitel, Robert Belshe, et al.
Vaccine|January 23, 2002
Immunogenicity of second dose measles-mumps-rubella (MMR) vaccine and implications for serosurveillanceR G Pebody, N J Gay, L M Hesketh, et al.
Vaccine|January 23, 2002
Construction and in vitro characterization of a molecularly cloned human immunodeficiency virus type 1 libraryTetsu Mukai, Takeshi Kurosu, Masanobu Kinomoto, et al.
Vaccine|January 31, 2002
Immunization with a DNA vaccine expressing a truncated form of varicella zoster virus glycoprotein EU A Hasan, D R Harper, B W Wren, et al.
Pageof 2,928

Showing results (81-90 of 29,276) with videos related to

Sort By:
Pageof 2,928
Vaccine|June 8, 2001
Protective immunity against influenza A virus induced by immunization with DNA plasmid containing influenza M geneK Okuda, A Ihata, S Watabe, et al.
Vaccine|June 8, 2001
Plasmid DNA-recombinant Opc protein complexes for nasal DNA immunizationA Musacchio, D Quintana, A M Herrera, et al.
Vaccine|June 8, 2001
Antibody, cytokine and cytotoxic T lymphocyte responses in chimpanzees immunized with human papillomavirus virus-like particlesT J Palker, J M Monteiro, M M Martin, et al.
Vaccine|June 8, 2001
Vaxfectin enhances antigen specific antibody titers and maintains Th1 type immune responses to plasmid DNA immunizationL Reyes, J Hartikka, V Bozoukova, et al.
Vaccine|June 8, 2001
Intranasal immunogenicity of a Delta cya Delta crp-pabA mutant of Salmonella enterica serotype Typhimurium for the horseA S Sheoran, J F Timoney, S A Tinge, et al.
Vaccine|January 23, 2002
Mutant Escherichia coli heat-labile enterotoxin [LT(R192G)] enhances protective humoral and cellular immune responses to orally administered inactivated influenza vaccineXiuhua Lu, J D Clements, Jacqueline M Katz
Vaccine|January 23, 2002
Evaluation of a single dose of half strength inactivated influenza vaccine in healthy adultsJohn Treanor, Wendy Keitel, Robert Belshe, et al.
Vaccine|January 23, 2002
Immunogenicity of second dose measles-mumps-rubella (MMR) vaccine and implications for serosurveillanceR G Pebody, N J Gay, L M Hesketh, et al.
Vaccine|January 23, 2002
Construction and in vitro characterization of a molecularly cloned human immunodeficiency virus type 1 libraryTetsu Mukai, Takeshi Kurosu, Masanobu Kinomoto, et al.
Vaccine|January 31, 2002
Immunization with a DNA vaccine expressing a truncated form of varicella zoster virus glycoprotein EU A Hasan, D R Harper, B W Wren, et al.
Pageof 2,928